FGWP
PFE icon

Founders Grove Wealth Partners’s Pfizer PFE Stock Holding History

Founders Grove Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Buy
+8,493
New +$226K 0.05% 147

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Founders Grove Wealth Partners's PFE Position: Q1 2026 in Review

Founders Grove Wealth Partners opened a new position in Pfizer (PFE) in Q1 2026: 8,493 shares worth $238K. The stake represents 0.05% of the portfolio and ranks #147 among its holdings.

2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Founders Grove Wealth Partners held 8,493 shares of Pfizer worth $238K as of Q1 2026.
  • Pfizer was a new Founders Grove Wealth Partners position in Q1 2026.
  • Pfizer made up 0.05% of Founders Grove Wealth Partners's portfolio in Q1 2026, its #147 holding.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Founders Grove Wealth Partners's 13F filing for Q1 2026, filed 15 Apr 2026.